Biosenta Inc. (CSE:ZRO)
Canada
· Delayed Price · Currency is CAD 0.1500
0.00 (0.00%)
Apr 25, 2025, 3:39 PM EDT
Biosenta Income Statement
Financials in millions CAD. Fiscal year is October - September.
Millions CAD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2015 - 2019 |
| Revenue | 0 | 0 | 0 | 0 | 0.17 | 0 | Upgrade
|
| Revenue Growth (YoY) | 81.02% | 32.34% | -9.47% | -99.31% | 10887.26% | - | Upgrade
|
| Cost of Revenue | 0 | 0 | 0 | 0.03 | 0.08 | 0 | Upgrade
|
| Gross Profit | 0 | 0 | -0 | -0.03 | 0.09 | 0 | Upgrade
|
| Selling, General & Admin | 1.06 | 1.06 | 1.41 | 1.08 | 2.02 | 0.67 | Upgrade
|
| Research & Development | 0.05 | 0.04 | 0.07 | 0.1 | 0.08 | 0.03 | Upgrade
|
| Operating Expenses | 1.11 | 1.1 | 1.48 | 1.19 | 2.1 | 0.7 | Upgrade
|
| Operating Income | -1.11 | -1.1 | -1.48 | -1.22 | -2.01 | -0.7 | Upgrade
|
| Interest Expense | -1.22 | -1.13 | -0.06 | -0.22 | -0.01 | -0.04 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.01 | 0 | 0 | -0.01 | -0 | -0 | Upgrade
|
| Other Non Operating Income (Expenses) | -0 | 0.01 | 0.03 | -0.01 | -0.02 | -0.02 | Upgrade
|
| EBT Excluding Unusual Items | -2.34 | -2.23 | -1.51 | -1.46 | -2.04 | -0.77 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | -4.79 | - | - | - | Upgrade
|
| Other Unusual Items | - | - | - | - | - | 0.01 | Upgrade
|
| Pretax Income | -2.34 | -2.23 | -6.3 | -1.46 | -2.04 | -0.76 | Upgrade
|
| Net Income | -2.34 | -2.23 | -6.3 | -1.46 | -2.04 | -0.76 | Upgrade
|
| Net Income to Common | -2.34 | -2.23 | -6.3 | -1.46 | -2.04 | -0.76 | Upgrade
|
| Shares Outstanding (Basic) | 31 | 30 | 26 | 21 | 18 | 16 | Upgrade
|
| Shares Outstanding (Diluted) | 31 | 30 | 26 | 21 | 18 | 16 | Upgrade
|
| Shares Change (YoY) | 14.98% | 13.05% | 22.74% | 19.71% | 11.27% | 13.73% | Upgrade
|
| EPS (Basic) | -0.08 | -0.08 | -0.24 | -0.07 | -0.11 | -0.05 | Upgrade
|
| EPS (Diluted) | -0.08 | -0.08 | -0.24 | -0.07 | -0.11 | -0.05 | Upgrade
|
| Free Cash Flow | -0.64 | -0.78 | -0.57 | -0.5 | -0.67 | -0.32 | Upgrade
|
| Free Cash Flow Per Share | -0.02 | -0.03 | -0.02 | -0.02 | -0.04 | -0.02 | Upgrade
|
| Gross Margin | 61.65% | 60.55% | -291.36% | - | 54.23% | 3.60% | Upgrade
|
| Operating Margin | -66561.05% | -80027.12% | -142275.24% | -105790.62% | -1194.37% | -46046.34% | Upgrade
|
| Profit Margin | -140445.24% | -161543.00% | -604582.92% | -126695.14% | -1214.64% | -49797.91% | Upgrade
|
| Free Cash Flow Margin | -38311.56% | -56515.45% | -54351.92% | -43825.63% | -399.92% | -20897.32% | Upgrade
|
| EBITDA | - | -1.1 | - | - | - | - | Upgrade
|
| D&A For EBITDA | - | 0 | - | - | - | - | Upgrade
|
| EBIT | -1.11 | -1.1 | -1.48 | -1.22 | -2.01 | -0.7 | Upgrade
|
| Revenue as Reported | - | - | - | - | 0.17 | 0 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.